| Year |
Citation |
Score |
| 2022 |
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, et al. Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]). Critical Care Medicine. PMID 36218354 DOI: 10.1097/CCM.0000000000005683 |
0.403 |
|
| 2021 |
Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É. Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cellular & Molecular Immunology. 18: 2578-2580. PMID 34588630 DOI: 10.1038/s41423-021-00771-z |
0.518 |
|
| 2021 |
Piperoglou C, Larid G, Vallentin B, Balligand L, Crinier A, Banzet N, Farnarier C, Gomez-Massa E, Adalia AC, Michel G, Galambrun C, Barlogis V, Vivier E, Vély F. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Journal of Leukocyte Biology. PMID 33847423 DOI: 10.1002/JLB.5A1019-522RR |
0.576 |
|
| 2020 |
Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É. Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cellular & Molecular Immunology. 18: 1290-1304. PMID 33239726 DOI: 10.1038/s41423-020-00574-8 |
0.607 |
|
| 2020 |
Carvelli J, Demaria O, Vély F, Batista L, Benmansour NC, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, André P, Represa A, Piperoglou C, Cordier PY, et al. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature. PMID 32726800 DOI: 10.1038/s41586-020-2600-6 |
0.501 |
|
| 2020 |
Demaria O, Carvelli J, Batista L, Thibult ML, Morel A, André P, Morel Y, Vély F, Vivier E. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19. Cellular & Molecular Immunology. PMID 32612152 DOI: 10.1038/s41423-020-0493-9 |
0.563 |
|
| 2018 |
Crinier A, Milpied P, Escalière B, Piperoglou C, Galluso J, Balsamo A, Spinelli L, Cervera-Marzal I, Ebbo M, Girard-Madoux M, Jaeger S, Bollon E, Hamed S, Hardwigsen J, Ugolini S, et al. High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice. Immunity. 49: 971-986.e5. PMID 30413361 DOI: 10.1016/j.immuni.2018.09.009 |
0.605 |
|
| 2018 |
Vivier E, Vély F, Fischer A. Reply to 'Comment on: Evidence of innate lymphoid cell redundancy in humans'. Nature Immunology. PMID 30026478 DOI: 10.1038/s41590-018-0165-4 |
0.573 |
|
| 2018 |
Boutboul D, Kuehn HS, Van de Wyngaert Z, Niemela JE, Callebaut I, Stoddard J, Lenoir C, Barlogis V, Farnarier C, Vely F, Yoshida N, Kojima S, Kanegane H, Hoshino A, Hauck F, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. The Journal of Clinical Investigation. PMID 29889099 DOI: 10.1172/Jci98164 |
0.355 |
|
| 2018 |
Vély F, Golub R, Vivier E. HLA-Fatal attraction. Nature Immunology. 17: 1012-4. PMID 27540985 DOI: 10.1038/ni.3541 |
0.393 |
|
| 2017 |
Ebbo M, Crinier A, Vély F, Vivier E. Innate lymphoid cells: major players in inflammatory diseases. Nature Reviews. Immunology. 17: 665-678. PMID 28804130 DOI: 10.1038/nri.2017.86 |
0.5 |
|
| 2017 |
Frazao A, Colombo M, Fourmentraux-Neves E, Messaoudene M, Rusakiewicz S, Zitvogel L, Vivier E, Vely F, Faure F, Dreno B, Benlalam H, Bouquet F, Savina A, Pasmant E, Toubert A, et al. Shifting the balance of activating and inhibitory natural killer receptor ligands on BRAF(V600E)melanoma lines with vemurafenib. Cancer Immunology Research. PMID 28576831 DOI: 10.1158/2326-6066.Cir-16-0380 |
0.608 |
|
| 2017 |
Cottineau J, Kottemann MC, Lach FP, Kang YH, Vély F, Deenick EK, Lazarov T, Gineau L, Wang Y, Farina A, Chansel M, Lorenzo L, Piperoglou C, Ma CS, Nitschke P, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. The Journal of Clinical Investigation. PMID 28414293 DOI: 10.1172/Jci90727 |
0.537 |
|
| 2017 |
Rusakiewicz S, Perier A, Semeraro M, Pitt JM, Pogge von Strandmann E, Reiners KS, Aspeslagh S, Pipéroglou C, Vély F, Ivagnes A, Jegou S, Halama N, Chaigneau L, Validire P, Christidis C, et al. NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients. Oncoimmunology. 6: e1137418. PMID 28197361 DOI: 10.1080/2162402X.2015.1137418 |
0.487 |
|
| 2016 |
Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, et al. Corrigendum: Evidence of innate lymphoid cell redundancy in humans. Nature Immunology. 17: 1479. PMID 27849206 DOI: 10.1038/ni1216-1479b |
0.575 |
|
| 2016 |
Xu X, Narni-Mancinelli E, Cantoni C, Li Y, Guia S, Gauthier L, Chen Q, Moretta A, Vély F, Eisenstein E, Rangarajan S, Vivier E, Mariuzza RA. Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30. Journal of Molecular Biology. PMID 27663271 DOI: 10.1016/j.jmb.2016.09.011 |
0.537 |
|
| 2016 |
Beldi-Ferchiou A, Lambert M, Dogniaux S, Vély F, Vivier E, Olive D, Dupuy S, Levasseur F, Zucman D, Lebbé C, Sène D, Hivroz C, Caillat-Zucman S. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma. Oncotarget. PMID 27662664 DOI: 10.18632/oncotarget.12150 |
0.549 |
|
| 2016 |
Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, et al. Evidence of innate lymphoid cell redundancy in humans. Nature Immunology. PMID 27618553 DOI: 10.1038/ni.3553 |
0.585 |
|
| 2016 |
Ebbo M, Gérard L, Carpentier S, Vély F, Cypowyj S, Farnarier C, Vince N, Malphettes M, Fieschi C, Oksenhendler E, Schleinitz N, Vivier E. Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency. Ebiomedicine. 6: 222-30. PMID 27211564 DOI: 10.1016/j.ebiom.2016.02.025 |
0.636 |
|
| 2016 |
Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F, Laplanche A, Ploix S, Vimond N, Peguillet I, Théry C, Lacroix L, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 5: e1071008. PMID 27141373 DOI: 10.1080/2162402X.2015.1071008 |
0.323 |
|
| 2016 |
Vallentin B, Barlogis V, Piperoglou C, Cypowyj S, Zucchini N, Chéné M, Navarro F, Farnarier C, Vivier E, Vély F. Innate Lymphoid Cells in Cancer. Cancer Immunology Research. 3: 1109-14. PMID 26438443 DOI: 10.1158/2326-6066.CIR-15-0222 |
0.613 |
|
| 2015 |
Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, et al. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients. Science Translational Medicine. 7: 283ra55. PMID 25877893 DOI: 10.1126/Scitranslmed.Aaa2327 |
0.323 |
|
| 2013 |
Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, Farnarier C, Piperoglou C, Papazian L, Chaussabel D, Ugolini S, Vély F, Vivier E. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood. 122: 394-404. PMID 23687088 DOI: 10.1182/blood-2013-01-481705 |
0.53 |
|
| 2013 |
Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, et al. Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population. Plos One. 8: e60127. PMID 23613718 DOI: 10.1371/journal.pone.0060127 |
0.398 |
|
| 2012 |
Forel JM, Chiche L, Thomas G, Mancini J, Farnarier C, Cognet C, Guervilly C, Daumas A, Vély F, Xéridat F, Vivier E, Papazian L. Phenotype and functions of natural killer cells in critically-ill septic patients. Plos One. 7: e50446. PMID 23236375 DOI: 10.1371/journal.pone.0050446 |
0.556 |
|
| 2012 |
Chiche L, Forel JM, Thomas G, Farnarier C, Cognet C, Guervilly C, Zandotti C, Vély F, Roch A, Vivier E, Papazian L. Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients. Critical Care Medicine. 40: 3162-9. PMID 22971588 DOI: 10.1097/CCM.0b013e318260c90e |
0.53 |
|
| 2012 |
Lapidus N, de Lamballerie X, Salez N, Setbon M, Ferrari P, Delabre RM, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, et al. Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort. Bmc Public Health. 12: 417. PMID 22676272 DOI: 10.1186/1471-2458-12-417 |
0.388 |
|
| 2012 |
Narni-Mancinelli E, Jaeger BN, Bernat C, Fenis A, Kung S, De Gassart A, Mahmood S, Gut M, Heath SC, Estellé J, Bertosio E, Vely F, Gastinel LN, Beutler B, Malissen B, et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science (New York, N.Y.). 335: 344-8. PMID 22267813 DOI: 10.1126/Science.1215621 |
0.632 |
|
| 2011 |
Chiche L, Forel JM, Thomas G, Farnarier C, Vely F, Bléry M, Papazian L, Vivier E. The role of natural killer cells in sepsis. Journal of Biomedicine & Biotechnology. 2011: 986491. PMID 21629707 DOI: 10.1155/2011/986491 |
0.621 |
|
| 2010 |
Schleinitz N, Vély F, Harlé JR, Vivier E. Natural killer cells in human autoimmune diseases. Immunology. 131: 451-8. PMID 21039469 DOI: 10.1111/j.1365-2567.2010.03360.x |
0.602 |
|
| 2005 |
Stewart CA, Laugier-Anfossi F, Vély F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagné F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proceedings of the National Academy of Sciences of the United States of America. 102: 13224-9. PMID 16141329 DOI: 10.1073/pnas.0503594102 |
0.54 |
|
| 2005 |
Vély F, Vivier E. Natural killer cell receptor signaling pathway in mammals. Science's Stke : Signal Transduction Knowledge Environment. 2005: cm7. PMID 16014604 DOI: 10.1126/stke.2922005cm7 |
0.611 |
|
| 2005 |
Vély F, Vivier E. Natural killer cell receptor signaling pathway. Science's Stke : Signal Transduction Knowledge Environment. 2005: cm6. PMID 16014603 DOI: 10.1126/stke.2922005cm6 |
0.603 |
|
| 2005 |
Chiesa S, Tomasello E, Vivier E, Vély F. Coordination of activating and inhibitory signals in natural killer cells. Molecular Immunology. 42: 477-84. PMID 15607802 DOI: 10.1016/j.molimm.2004.07.030 |
0.556 |
|
| 2004 |
Vivier E, Nunès JA, Vély F. Natural killer cell signaling pathways. Science (New York, N.Y.). 306: 1517-9. PMID 15567854 DOI: 10.1126/science.1103478 |
0.623 |
|
| 2003 |
Ferjoux G, Lopez F, Esteve JP, Ferrand A, Vivier E, Vely F, Saint-Laurent N, Pradayrol L, Buscail L, Susini C. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. Molecular Biology of the Cell. 14: 3911-28. PMID 12972574 DOI: 10.1091/mbc.e03-02-0069 |
0.516 |
|
| Show low-probability matches. |